Target intelligence / Profile preview

RNA, U2 small nuclear 39, pseudogene (RNU2-39P)

Target
RNU2-39P
Molecular classification
Other, Non-coding RNA pseudogene
01

Overview

RNU2-39P is a non-protein-coding pseudogene in the human genome that resembles the sequence of functional U2 small nuclear RNA genes, which are essential components of the spliceosome responsible for pre-mRNA splicing[3][2]. Unlike the canonical U2 snRNA genes, pseudogenes such as RNU2-39P typically arise from duplication and mutation events and do not produce functional RNA products[3]. U2 snRNA pseudogenes are characterized by truncated or altered sequences and lack the necessary elements for stable expression and integration into spliceosomal complexes[3][2]. The known U2 snRNA family plays a critical role in mRNA splicing and post-transcriptional modifications, but pseudogenes like RNU2-39P do not participate in these cellular processes[3]. There is no evidence indicating RNU2-39P is involved in disease, serves as a drug target, or functions as a biomarker. Annotation confusion can arise due to the large number of U2 pseudogenes and challenges in mapping small RNA sequences, but RNU2-39P itself does not represent a receptor, enzyme, or therapeutic target[2][3].

Other names
RNU2-39PU2 small nuclear RNA pseudogene 39

Beyond the preview

Go deeper on RNA, U2 small nuclear 39, pseudogene (RNU2-39P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U2 small nuclear 39, pseudogene (RNU2-39P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call